The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.

This Advisory, based on TIP 49, Incorporating Alcohol Pharmacotherapies Into Medical Practice, focuses on medication and related treatment decisions made after screening and assessment for AUD, and medically supervised withdrawal, if necessary. Alcohol consumption should not stop abruptly in those patients who have consumed alcohol regularly over a prolonged period of time. This Advisory is meant as an overview of AUD medications to facilitate abstinence.

This action brief provides rural communities recommended strategies for adapting promising or proven interventions to better support crisis response and pre-arrest diversion in their communities. It is the first of three briefs developed from the SAMHSA Pre-Arrest Diversion Expert Panel. 

This report shines the spotlight on the critical issues and services for Americans with serious mental illnesses (SMI) and serious emotional disturbances (SED), and the importance of concerted efforts by the federal government to address their needs.  The report presents the current status of federal activities and a summary of advances in the care and treatment of people with SMI and SED.  The report describes key advances in research and strategies to improve services to these individuals based on presentations given by the Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC) members at the first ISMICC meeting.

This Executive Summary to the 2017 report to Congress shines the spotlight on the critical issues and services for Americans with serious mental illnesses (SMI) and serious emotional disturbances (SED). The 2017 report to congress represents the starting point in a five-year process of improving the lives of people with SMI and SED. This 8-page summary delineates the five focus areas, each with 8-10 recommendations. These recommendations are from the non-federal members and represent common areas in which federal partners and stakeholders can work together to implement over the next five years.

Describes the stages of recovery from alcohol and drug abuse and what to expect after leaving detoxification services. Offers guidance in adjusting to sobriety just after detox and through long-term recovery; discusses legal issues; and lists resources.

This Korean-language brochure describes the stages of recovery from people living with substance use disorders and what to expect after leaving detoxification services. It offers guidance on adjusting to sobriety and long-term recovery. The brochure also discusses legal issues and lists resources.

This report examines the opportunities and challenges associated with municipal court diversion for people living with mental illness and substance use disorder conditions. It outlines elements for effective diversion, recovery-based engagement strategies, and proportional response.

This guide educates substance use counselors and clinicians about detoxification and withdrawal. It addresses patient placement, detox services for specific substances, co-occurring disorders, financing issues, and screening and assessment tools.